Just In
- 53 min ago Shukra Rahu Yuti In April 2024: Check The List Of Lucky Zodiac Signs
- 3 hrs ago Daily Horoscope, 28 March 2024: Gemini Businessmen Will Witness Profits Today
- 11 hrs ago Summer Fashion: 7 Trendy Office Outfit Ideas To Beat The Heat In Style
- 12 hrs ago Good Friday 2024 Date: Why Are Chruch Bells Not Rung On Good Friday?
Don't Miss
- News Despite India's Objection, US Reiterates Remarks On Arvind Kejriwal's Arrest, Congress' Bank Accounts Freezing
- Finance Stock Market Live Updates: Nifty 50 Wants To End The March Series And FY24 Strongly
- Movies Tillu Square Sequel: Siddhu Jonnalagadda Confirms A SHOCKING Climax; Exciting Female Cameo & Lead To A Sequel
- Technology Poco C61 Goes on Sale in India at 12 noon Today via Flipkart: Check Price, Specs, Offers
- Sports Madrid Spain Masters 2024: PV Sindhu Eases Into Second Round; Kidambi Srikanth Bows Out Early
- Automobiles Citroen Basalt SUV Revealed In India – Launch Details & More
- Education IGNOU June TEE 2024 registration schedule out; Check out for more details
- Travel Explore Tamil Nadu's Diverse Wedding Venues
Covid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children
On Tuesday (26 April), the Drugs Controller General of India (DCGI) approved three Covid-19 vaccines for restricted emergency use authorisation (EUA) in children of various ages.
Bharat Biotech's Covaxin received a restricted EUA from the DCGI for children aged 6 to12. Similarly, Biological E's Covid-19 vaccine Corbevax has been approved for children aged 5 to 12 years.
Further, along with Corbevax and Covaxin, the DCGI has also approved Zydus Cadila's Covid-19 vaccine ZyCoV-D for children over the age of 12 years for a two-dose regimen.
This development happened after the Subject Expert Committee's (SEC) discussion of suggestions for the emergency use of Covaxin in children aged 6 to 12 years due to an increase in covid-19 cases in schools.
Covaxin has proven to be effective for adults and is also presently being given to youngsters aged 15 to 18. To give EUA to Covaxin for children aged 6-12 years, experts had requested more information from the corporation, which was delivered on Friday. The SEC was satisfied with the provided data and thus, nods for its EUA among children aged 6-12 years.
As the focus was mainly on the increasing number of cases among children, the SEC has also recommended emergency use of Biological E's Covid-19 vaccine Corbevax and ZyCoV-D.
- pregnancy parentingMysterious Pneumonia Outbreak In China: What Are The Long-Term Effects Of Pneumonia In Children?
- healthCan You Get Back COVID-Related Loss Of Sense Of Smell And Taste (Parosmia)? Looks Like You Can!
- healthDid Covid-10 Vaccination Increase Risk Of Sudden Deaths In Young Adults? ICMR Finds This..
- wellnessDelhi Air Pollution, Air Quality Very Poor: Do Covid Masks Help Reduce Pollution Side Effects?
- healthNobel Prize 2023: Scientists Behind The COVID-19 mRNA Vaccines Wins
- healthWhat Is Disease X? 20 Times More Deadlier Than Covid 19; Can Cause 50 Million Deaths, Does It Have Vaccine?
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- healthDo You Pick Your Nose? Stop! It Can Increase COVID Risk
- healthEris Variant: WHO Alarms New Covid Wave; Should India Be Concerned About This Pandemic
- healthVitamin D Deficiency Linked With Increased Risk Of Long COVID
- healthCOVID Surge In India: Do You Need A COVID-19 Booster Shot?
- healthCOVID-19: IMA Cites 3 Reasons Behind Recent Surge In Covid-19 Cases: What Are They?